Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents

- Chen, Qingjuan, Yang, Binhui, Liu, Xiaochen, Zhang, Xu D., Zhang, Lirong, Liu, Tao

Targeted therapy of TERT-rearranged neuroblastoma with BET bromodomain inhibitor and proteasome inhibitor combination therapy

- Chen, Jingwei, Nelson, Christopher, Wong, Matthew, Tee, Andrew E., Liu, Pei Y., La, Ting, Fletcher, Jamie I., Kamili, Alvin, Mayoh, Chelsea, Bartenhagen, Christoph, Trahair, Toby N., Xu, Ning, Jayatilleke, Nisitha, Wong, Marie, Peng, Hui, Atmadibrata, Bernard, Cheung, Belamy B., Lan, Qing, Bryan, Tracy M., Mestdagh, Pieter, Vandesompele, J, Combaret, V, Boeva, V, Wang, JY, Janoueix-Lerosey, I, Cowley, MJ, MacKenzie, KL, Dolnikov, A, Li, J, Polly, P, Marshall, GM, Reddel, RR, Norris, MD, Haber, M, Fischer, M, Zhang, Xu D., Pickett, HA, Liu, T

JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma

- Wong, Matthew, Sun, Yuting, Xi, Zhichao, Milazzo, Giorgio, Poulos, Rebecca C., Bartenhagen, Christoph, Bell, Jessica L., Mayoh, Chelsea, Ho, Nicholas, Tee, Andrew E., Chen, Xiaoqiong, Li, Yang, Ciaccio, Roberto, Liu, Pei Y., Jiang, Chen C., Lan, Qing, Jayatilleke, Nisitha, Cheung, Belamy B., Haber, Michelle, Norris, Murray D., Zhang, Xu D., Marshall, GM, Wang, JY, Huettelmaier, S, Fischer, M, Wong, JWH, Xu, H, Perini, G, Dong, Q, George, RE, Liu, T

The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35.

- Liu, Pei Y., Tee, Andrew E., Milazzo, Giorgio, Hannan, Katherine M., Maag, Jesper, Mondal, Sujanna, Atmadibrata, Bernard, Bartonicek, Nenad, Peng, Hui, Ho, Nicholas, Mayoh, Chelsea, Ciaccio, Roberto, Sun, Yuting, Henderson, Michelle J., Gao, Jixuan, Everaert, Celine, Hulme, Amy J., Wong, Matthew, Lan, Qing, Cheung, Belamy B., Zhang, Xu D.

The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs

- Liu, Pei Y., Sokolowski, Nicholas, Liu, Bing, Yang, Rui H., Guo, Xiang Y., Tee, Andrew E., Itoh, Ken, Wang, Jenny, Kavallaris, Maria, Haber, Michelle, Norris, Murray D., Cheung, Belamy B., Guo, Su T., Byrne, Jennifer A., Ziegler, David S., Marshall, Glenn M., Dinger, Marcel E., Codd, Rachel, Zhang, Xu D., Liu, Tao, Siddiqi, Faraz, Atmadibrata, Bernard, Telfer, Thomas J., Sun, Yuting, Zhang, Lihong, Yu, Denise, Mccarroll, Joshua

Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression

- Liu, Pei Y., Erriquez, Daniela, Cheung, Belamy B., Fox, Archa, Swarbrick, Alexander, Hüttelmaier, Stefan, Kavallaris, Maria, Perini, Giovanni, Mattick, John S., Dinger, Marcel E., Liu, Tao, Marshall, Glenn M., Tee, Andrew E., Polly, Patsie, Wong, Mathew, Liu, Bing, Bell, Jessica L., Zhang, Xu D., Milazzo, Giorgio

Oncogenic activation of MEK/ERK primes melanoma cells for adaptation to endoplasmic reticulum stress

- Croft, Amanda, Tay, Kwang H., Zhang, Xu D., Boyd, Suzanah C., Guo, Su T., Jiang, Chen C., Lai, Fritz, Tseng, Hsin-Yi, Jin, Lei, Rizos, Helen, Hersey, Peter

P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation

- Avery-Kiejda, Kelly A., Bowden, Nikola A., Hersey, Peter, Croft, Amanda J., Scurr, Lyndee L., Kairupan, Carla F., Ashton, Katie A., Talseth-Palmer, Bente A., Rizos, Helen, Zhang, Xu D., Scott, Rodney J.